EGFR-related peptide

General Information


DRACP ID  DRACP00123

Peptide Name   EGFR-related peptide

Sequence  ERRP

Sequence Length  4

UniProt ID  Not available

PubChem CID  Not available

Origin  EGFR-related peptide

Type  Native peptide

Classification

  

Active ACP



Activity Information


Cell Line Disease Cancer Classified Activity Assay Testing Time Literature
PC-3 Prostate carcinoma Carcinoma 30% Cell viability at 5 µg/ml MTT assay 48 h 1

Hemolytic Activity  Not available

Normal (non-cancerous) Cytotoxicity  Not available

Target  Not available

Affinity  Not available

Mechanism  ERRP inhibits the growth of prostate cancer cells by attenuating EGFR signaling processes

Nature  Anticancer



Structure Information


PDB ID  Not available

Predicted Structure  DRACP00123

Helicity  Not available

Linear/Cyclic  Linear

Disulfide/Other Bond  Not available

N-terminal Modification  Free

C-terminal Modification  Free

Other Modification  None

Chiral  L



Physicochemical Information


Formula  C22H40N10O7

Absent amino acids  ACDFGHIKLMNQSTVWY

Common amino acids  R

Mass  61030

Pl  10.4

Basic residues  2

Acidic residues  1

Hydrophobic residues  0

Net charge  1

Boman Index  -3665

Hydrophobicity  -352.5

Aliphatic Index  0

Half Life 
  Mammalian: 4.4 hour
  Yeast: >20 hour
  E.coli: >10 hour

Extinction Coefficient cystines  0

Absorbance 280nm  0

Polar residues  0

Amino acid distribution



Literature Information


Literature 1

Pubmed ID 15634655

Title  Epidermal growth factor receptor-related peptide inhibits growth of PC-3 prostate cancer cells

Doi Not available

Year  2004

Patent

Patent ID Not available

Patent Title  Not available

Other Iinformation  Not available

Other Published ID  Not available




DRACP is developed by Dr.Zheng's team.